Analystreport

Syndax Pharmaceuticals Inc (NASDAQ: SNDX) had its price target lowered by analysts at Barclays PLC from $25.00 to $23.00. They now have an "overweight" rating on the stock.

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com